MoneyWorks4Me

Krebs Biochemicals to raise funds up to Rs 25 crore

31 Jul 2018 Evaluate

Krebs Biochemicals & Industries has received an approval for raising of funds by way of offer and issue of Equity Shares to the members of the company on rights basis (Rights Issue) at such price and rights entitlement ratio as may be decided by the Board/committee of the Board, for an amount aggregating up to Rs 25 crore. The Board of Directors of the company in its meeting on July 30, 2018, approved the same.

Krebs Biochemicals & Industries is an India-based company. The Company operates in the pharma segment.


Peers
Company Name CMP
Sun Pharma. Inds. 1856.25
Dr. Reddys Labs. 1205.00
Cipla 1402.50
Lupin 2099.00
Zydus Lifesciences 1175.00
View more..